News

Call us on 0113 202 9799

News

Breath biopsy to be used in COPD trial

As reported in The Pharma Times,  GlaxoSmithKline is incorporating Owlstone Medical's, Breath Biopsy platform into the clinical development programme for its novel, experimental respiratory drug danirixin. GSK will ...

Read More

Drug Discovery News: Recruitment in practice

LEEDS, U.K.—With a goal of achieving quicker, more efficient and more effective clinical research and trials, Interface Clinical Research—just launched at the Royal Society of London in January—is offering detailed ...

Read More

Interface Clinical Research identifies thousands of patients for feasibility studies in a number of days

Interface Clinical Research has identified thousands of suitable patients for sponsors in feasibility studies for type-2 diabetes and chronic kidney disease (CKD). Interface was able to identify these patients from four of ...

Read More

New Clinical Trials Model featured in CenterWatch

New clinical trials model: Move to local GP practices to solve patient drop out crisis   An infographic published by CenterWatch this week shows that 58% of study volunteers decline consent for a trial, 32% fail the ...

Read More

Fill in the form below to send Interface Clinical Research a message, and we will get back to you as soon as possible.


I want to receive monthly newsletters.